KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Gross Profit (2016 - 2025)

Charles River Laboratories International has reported Gross Profit over the past 17 years, most recently at $744.9 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 305.17% year-over-year to $744.9 million; the TTM value through Dec 2025 reached $2.2 billion, up 41.55%, while the annual FY2025 figure was $3.4 billion, 46.17% up from the prior year.
  • Gross Profit for Q4 2025 was $744.9 million at Charles River Laboratories International, up from $596.7 million in the prior quarter.
  • Over five years, Gross Profit peaked at $1.9 billion in Q4 2021 and troughed at -$363.1 million in Q4 2024.
  • A 5-year average of $589.4 million and a median of $473.6 million in 2022 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: plummeted 152.25% in 2024 and later skyrocketed 305.17% in 2025.
  • Year by year, Gross Profit stood at $1.9 billion in 2021, then plummeted by 73.94% to $496.7 million in 2022, then soared by 39.91% to $695.0 million in 2023, then crashed by 152.25% to -$363.1 million in 2024, then skyrocketed by 305.17% to $744.9 million in 2025.
  • Business Quant data shows Gross Profit for CRL at $744.9 million in Q4 2025, $596.7 million in Q3 2025, and $447.3 million in Q2 2025.